Skip to Content

TEVA 5347 (Methylphenidate Hydrochloride Extended-Release (LA) 30 mg)

Pill with imprint TEVA 5347 is White, Capsule-shape and has been identified as Methylphenidate Hydrochloride Extended-Release (LA) 30 mg. It is supplied by Teva Pharmaceuticals USA Inc..

Methylphenidate is used in the treatment of adhd; narcolepsy; depression; fatigue; obesity (and more), and belongs to the drug class CNS stimulants. Risk cannot be ruled out during pregnancy. Methylphenidate 30 mg is classified as a Schedule 2 controlled substance under the Controlled Substance Act (CSA).

Images for TEVA 5347

Methylphenidate hydrochloride extended-release (LA) 30 mg TEVA 5347

Methylphenidate Hydrochloride Extended-Release (LA)

Imprint:
TEVA 5347
Strength:
30 mg
Color:
White
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
CNS stimulants
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
2 - High potential for abuse
Labeler / Supplier:
Teva Pharmaceuticals USA Inc.
National Drug Code (NDC):
00093-5347

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide